Klivira
Request demo

Streamlining Allergy & Immunology Specialty Drug Prior Auth

For allergy and immunology practices, managing specialty drug prior auth for biologics and immunotherapies is a complex, high-stakes process. Klivira automates this critical workflow to accelerate patient access to therapy.

The administration of high-cost specialty drugs, including biologics and advanced immunotherapies, is central to modern allergy & immunology care. However, securing prior authorization for these therapies often introduces significant administrative burden, delays patient access, and impacts revenue cycles. Klivira addresses these challenges by automating the intricate specialty drug PA workflow.

The Unique Challenges of Allergy & Immunology Specialty Drug Prior Auth

Allergy & Immunology practices frequently prescribe high-cost, high-complexity specialty drugs such as asthma biologics (e.g., Xolair, Dupixent, Nucala), IVIG/SCIG, and allergen immunotherapy. Each of these therapies often triggers a prior authorization requirement, necessitating detailed clinical documentation, benefit-side determination, and adherence to payer-specific step-therapy protocols. The volume and specificity of these PAs can overwhelm administrative staff, leading to delays in crucial patient care.

Common Prior Authorization Triggers in A&I

  • Biologics for severe asthma and other allergic conditions
  • Intravenous Immunoglobulin (IVIG) and Subcutaneous Immunoglobulin (SCIG) for primary immunodeficiencies
  • Advanced allergen immunotherapy regimens
  • Specialty medications for chronic urticaria or angioedema
  • High-cost oral targeted therapies for inflammatory conditions

Manual Workflow: A Barrier to Timely A&I Care

Without automation, allergy & immunology practices face a multi-step, manual process for specialty drug PAs. This begins with determining whether the drug falls under the medical or pharmacy benefit, a common point of misclassification. Pharmacy benefit drugs often route through PBM-specific ePA channels like CoverMyMeds or Surescripts ePA using the NCPDP SCRIPT standard. Medical benefit drugs require submission via payer portals, X12 278 EDI, or, where available, Da Vinci PAS. Each path demands specific clinical data, prior-line therapy history, and often, site-of-care optimization.

Klivira's Automated Approach for A&I Specialty Drugs

Klivira's platform provides a comprehensive solution for allergy & immunology specialty drug prior authorization. We automate the critical benefit-side determination, accurately identifying whether a drug falls under medical or pharmacy benefit per drug, payer, and patient context. This ensures submissions are routed correctly from the outset, eliminating a common failure point that delays access to essential therapies like asthma biologics or IVIG.

Integrated Workflow and Standards Compliance

Our system integrates seamlessly with EMRs to extract necessary clinical documentation, including medication history and treatment response data, utilizing FHIR MedicationRequest and Observation resources to populate step-therapy requirements. For pharmacy-benefit drugs, Klivira routes through established ePA partners using NCPDP SCRIPT ePA. For medical-benefit drugs, we support submissions via payer portals, X12 278, and Da Vinci PAS where available. This multi-channel capability ensures broad payer coverage and compliance with industry standards, critical for the diverse range of specialty drugs in allergy and immunology.

Optimizing Site-of-Care and Specialty Pharmacy Fulfillment

Klivira's logic incorporates payer site-of-care policies, flagging requirements for alternative infusion sites (e.g., home infusion vs. hospital outpatient) before submission, which is crucial for medical-benefit specialty drugs like IVIG. Post-approval, for pharmacy-benefit drugs, Klivira coordinates the handoff to the payer's specialty pharmacy partner (e.g., Accredo, CVS Specialty, Optum Specialty), streamlining fulfillment and reducing time-to-medication for allergy patients.

Frequently asked questions

How does Klivira handle the medical vs. pharmacy benefit split for allergy & immunology drugs?

Klivira's policy engine automates benefit-side determination, accurately identifying whether a specialty drug, such as an asthma biologic or IVIG, falls under the medical or pharmacy benefit for a specific payer and patient. This ensures the prior authorization request is routed to the correct channel (e.g., NCPDP SCRIPT ePA for pharmacy, X12 278 for medical), preventing misclassification delays.

Can Klivira integrate with our EMR to pull clinical data for biologic prior authorizations?

Yes, Klivira integrates with your EMR to automatically extract relevant clinical documentation. For allergy & immunology specialty drugs, this includes medication history and treatment-response data from FHIR MedicationRequest and Observation resources, which is essential for fulfilling step-therapy and medical necessity requirements for biologics.

What role does site-of-care play in prior auth for IVIG, and how does Klivira address it?

Site-of-care is a critical factor for medical-benefit specialty drugs like IVIG, as payers often have policies steering toward less expensive settings. Klivira's system incorporates payer site-of-care logic, surfacing these requirements before submission and ensuring your PA aligns with payer policy, reducing the likelihood of denials related to site-of-care.

Does Klivira help with step-therapy requirements for asthma biologics?

Absolutely. Klivira automates the documentation of step-therapy and prior-line therapy history by reading medication and treatment data from your EMR via FHIR resources. This ensures that all necessary evidence for asthma biologic approvals is included in the prior authorization submission, aligning with payer guidelines.

How does Klivira support specialty pharmacy fulfillment for allergy patients?

For pharmacy-benefit specialty drugs, Klivira coordinates the post-approval workflow. After a prior authorization is approved, our system facilitates the handoff to the payer's specialty pharmacy partner, such as Accredo or CVS Specialty, streamlining the fulfillment process and helping to reduce delays in patient access to their medications.

Related coverage

Other allergy-immunology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo